EUVIMEDEUVIMED entdecken
Crossref

Lipofilling in the comprehensive treatment of vulvar lichen sclerosus: pathogenetic rationale and first clinical results

Anna A. Tsypurdeeva, Julia V. Kudlay, Karina А. Zakuraeva, Elena I. Rusina, Maria I. Yarmolinskaya

Journal of obstetrics and women's diseases · 29.06.2026 · 75 (3) · 114-123

DOI: 10.17816/jowd707600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of obstetrics and women's diseases, online erschienen am 29.06.2026. Verfasst von Anna A. Tsypurdeeva und 4 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vulvar lichen sclerosus is a chronic immune-mediated disease associated with inflammation, atrophy, fibrosis, and genital scarring. Although topical glucocorticosteroids remain the first-line therapy and are effective in controlling inflammatory symptoms, some patients develop persistent anatomical and functional impairment, including synechiae, vaginal stenosis, dyspareunia, and reduced quality of life. This supports the need for additional treatment approaches. This review article presents a series of three clinical cases involving patients aged 48, 55, and 62 years with verified vulvar lichen sclerosus with clinically significant scarring and atrophic changes. Treatment included lipofilling of the external genitalia using microfragmented autologous lipoaspirate obtained by closed double microfiltration; in two patients, the procedure was combined with laser dissection of synechiae. Treatment outcomes were assessed by clinical examination, symptom dynamics, photographic documentation, and restoration of vulvar anatomy and functional status. The follow-up period ranged from 1.5 to 6 months. In the short-term follow-up period, all patients showed a reduction in symptoms, including pain, itching, burning, and discomfort, as well as improved vulvar tissue elasticity. In patients with baseline synechiae, combined treatment resulted in restoration of the anatomical patency of the vaginal introitus, with no recurrence of synechiae during follow-up visits. Patients with baseline sexual dysfunction reported resumption of sexual activity. No adverse events, infectious complications, or signs of disease worsening were observed during the follow-up period. The presented clinical observations suggest that lipofilling, including its combination with laser dissection of synechiae, may be considered a potentially promising component of comprehensive treatment for patients with scarring and atrophic manifestations of vulvar lichen sclerosus. These findings are preliminary and require confirmation in prospective controlled studies with larger patient cohorts, using validated symptom and quality-of-life assessment scales and long-term follow-up.

Zitieren

APA

Tsypurdeeva, A. A., Kudlay, J. V., Zakuraeva, K. А., Rusina, E. I., & Yarmolinskaya, M. I. (2026). Lipofilling in the comprehensive treatment of vulvar lichen sclerosus: pathogenetic rationale and first clinical results. Journal of obstetrics and women's diseases, 75(3), 114-123. https://doi.org/10.17816/jowd707600

Vancouver

Tsypurdeeva AA, Kudlay JV, Zakuraeva KА, Rusina EI, Yarmolinskaya MI. Lipofilling in the comprehensive treatment of vulvar lichen sclerosus: pathogenetic rationale and first clinical results. Journal of obstetrics and women's diseases. 2026;75(3):114-123. doi:10.17816/jowd707600

BibTeX
@article{Tsypurdeeva2026,
  author = {Tsypurdeeva, Anna A. and Kudlay, Julia V. and Zakuraeva, Karina А. and Rusina, Elena I. and Yarmolinskaya, Maria I.},
  title = {Lipofilling in the comprehensive treatment of vulvar lichen sclerosus: pathogenetic rationale and first clinical results},
  journal = {Journal of obstetrics and women's diseases},
  year = {2026},
  volume = {75},
  number = {3},
  pages = {114--123},
  doi = {10.17816/jowd707600}
}
Kostenlos starten →